Mdka Produced by the Activated Hepatic Stellate Cells Drives Bipotential Progenitor Cell Redifferentiation During Zebrafish Biliary-Mediated Liver Regeneration

Xintao Zhang,Huijuan Liu,Pengcheng Cai,Zhuofu Huang,Jianlong Ma,Lingfei Luo
DOI: https://doi.org/10.1097/hep.0000000000001031
IF: 17.298
2024-01-01
Hepatology
Abstract:Background and Aims: After extensive hepatocyte loss or impaired hepatocyte proliferation, liver regeneration occurs via transdifferentiation of biliary epithelial cells (BECs), which involves dedifferentiation of BECs into bipotential progenitor cells (BP-PCs) and subsequent redifferentiation of BP-PCs into nascent hepatocytes and BECs. Despite several studies on the redifferentiation process of BP-PCs into nascent hepatocytes, the contributions of nonparenchymal cells in this process remain poorly understood. Approach and Results: Using the zebrafish severe liver injury model, we observed specific expression of midkine a (Mdka) in the activated hepatic stellate cells (HSCs) through single-cell analyses and fluorescence in situ hybridization (FISH). Genetic mutation, pharmacological inhibition, whole-mount in situ hybridizations (WISH), and antibody staining demonstrated an essential role of mdka in the redifferentiation of BP-PCs during liver regeneration. Notably, we identified Nucleolin (Ncl), the potential receptor for Mdka, specifically expressed in BP-PCs, and its mutant recapitulated the mdka mutant phenotypes with impaired BP-PC redifferentiation. Mechanistically, the Mdka-Ncl axis drove Erk1 activation in BP-PCs during liver regeneration. Furthermore, overexpression of activated Erk1 partially rescued the defective liver regeneration in the mdka mutant. Conclusions: The activated HSCs produce Mdka to drive the redifferentiation process of BP-PCs through activating Erk1 during the biliary-mediated liver regeneration, implying previously unappreciated contributions of nonparenchymal cells to this regeneration process.
What problem does this paper attempt to address?